R-CHOP Chemotherapy
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: November 2026
Definition: A highly effective combination treatment used primarily for non-Hodgkin lymphoma, made up of three chemotherapy drugs, a targeted therapy agent, and a steroid. [1]
Schedule: Typically given in three-week cycles over several months. [1]
Outcomes: A strong track record, with up to 70% of patients achieving long-term remission, according to the source guide.
Side effects: Significant, including fatigue and hair loss, yet it remains a cornerstone of modern lymphoma care.
Quick Answer
R-CHOP is a chemotherapy regimen that treats non-Hodgkin lymphoma with five drugs: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. [1] It attacks fast-growing cancer cells while helping the immune system identify and destroy them. [1] Usually given in six cycles over 18 weeks, it has high success rates in achieving complete remission in various B-cell lymphomas.
What the research says
Adding rituximab to CHOP improved long-term survival. In the LNH-98.5 randomized trial of 399 patients with diffuse large B-cell lymphoma aged 60 to 80, 10-year progression-free survival was 36.5% with R-CHOP versus 20% with CHOP alone, and 10-year overall survival was 43.5% versus 27.6% (Coiffier et al., Blood, 2010) [2].
In a large modern trial, about 59% of R-CHOP patients were progression-free at five years. In the POLARIX trial of 879 patients with previously untreated intermediate- or high-risk diffuse large B-cell lymphoma, 5-year progression-free survival was 59.1% (95% CI 53.9 to 64.3) with R-CHOP and 64.9% (95% CI 59.8 to 70.0) with the newer Pola-R-CHP regimen (hazard ratio 0.77), with similar long-term tolerability (Morschhauser et al., J Clin Oncol, 2025) [3].
How does R-CHOP chemotherapy work?
R-CHOP chemotherapy, often referred to as immuno-chemotherapy, represents a powerful multi-drug approach to treating non-Hodgkin lymphoma. [1] By combining traditional chemotherapy with modern targeted therapy, healthcare providers can attack cancer cells from multiple angles simultaneously. This synergy is particularly effective against aggressive forms of the disease, such as diffuse large B-cell lymphoma (DLBCL), where the goal is often complete and lasting remission.
The treatment is structured to maximize cancer cell destruction while allowing the body time to recover between doses. Each component of the regimen plays a specific role, from directly killing rapidly dividing cells to modulating the immune response. Because it involves several potent medications, R-CHOP is administered under close medical supervision, often in a specialized infusion center or hospital setting.
Drug Component | Type of Therapy | Primary Function |
Rituximab (R) | Targeted Therapy | Attaches to cancer cell proteins to signal immune destruction. |
Cyclophosphamide (C) | Chemotherapy | Interferes with cancer cell DNA to stop growth. |
Doxorubicin (H) | Chemotherapy | Kills cancer cells by blocking essential growth enzymes. |
Vincristine (O) | Chemotherapy | Prevents cancer cells from dividing and multiplying. |
Prednisone (P) | Corticosteroid | Kills cancer cells and reduces the risk of allergic reactions. |
What is the R-CHOP chemotherapy schedule, and how many cycles are given?
R-CHOP is typically administered in cycles, with each cycle lasting three weeks (21 days). [1] A standard course of treatment usually consists of six cycles, totaling 18 weeks, though some patients may require up to eight cycles depending on their specific diagnosis and response. Each cycle is divided into treatment days, where medications are administered, and rest days, which allow the body's healthy cells to recuperate. [1]
On the first day of each cycle, patients receive the four injectable medications via an intravenous (IV) infusion. [1] Rituximab is often administered slowly during the first cycle—sometimes taking up to eight hours—to monitor for potential reactions. [1] The remaining chemotherapy drugs are usually given in shorter infusions ranging from 10 to 30 minutes each. [1] Prednisone is taken as an oral pill for the first five days of every cycle. [1]
What are the common side effects of R-CHOP chemotherapy, and how are they managed?
Like all intensive cancer treatments, R-CHOP causes a range of side effects as it affects both cancerous and healthy fast-growing cells. Fatigue is the most frequently reported symptom, particularly during the 16 rest days of each cycle. Many patients also experience temporary hair loss, nausea, and a heightened risk of infection due to lower white blood cell counts. [1]
A unique but harmless side effect of the drug doxorubicin is the appearance of reddish or pink urine for up to 48 hours after an infusion. [1] Healthcare providers proactively manage other side effects by prescribing anti-nausea medications and sometimes administering drugs to boost white blood cell production. [1] Maintaining hydration and following a balanced diet are also essential components of self-care during the recovery periods. [1]
How successful is R-CHOP chemotherapy, and what is the long-term outlook?
The clinical success of R-CHOP is one of the primary reasons it remains a first-line treatment for non-Hodgkin lymphoma. Studies show that roughly 60% to 70% of people with diffuse large B-cell lymphoma remain free of progression five years after R-CHOP, with lower rates in older or higher-risk patients. [1] For many patients, reaching the five-year milestone without a recurrence indicates a very high likelihood of long-term survival.
Outcome Metric | Expected Result with R-CHOP |
Complete Remission Rate (DLBCL) | Approximately 70% |
Standard Treatment Duration | 18 to 24 weeks |
Long-term Monitoring Period | 5 years post-treatment |
Primary Goal | Elimination of all detectable cancer symptoms |
What is daily life like during R-CHOP chemotherapy?
Although R-CHOP chemotherapy is a demanding treatment, many patients find they can maintain some level of normal activity during their rest days. Light exercise, such as walking, is often encouraged if energy levels permit. [1] It is important for patients to have a strong support system in place to help with daily tasks, especially during the first few days after an infusion when fatigue and nausea may be most prominent. Call your care team right away for a fever of 100.4°F (38°C) or higher, chills or other signs of infection, because low white blood cell counts can make infections dangerous. You will be tested for hepatitis B before starting, because rituximab can reactivate it, and your heart may be checked because doxorubicin can affect heart function.
Conclusion
R-CHOP is a cornerstone of lymphoma treatment, offering a high probability of success through its sophisticated combination of five different medications. By integrating targeted therapy with traditional chemotherapy, it provides a comprehensive defense against non-Hodgkin lymphoma. While the journey through multiple treatment cycles can be challenging, the potential for lasting remission makes it a vital option for thousands of patients every year.
What should you do next if R-CHOP chemotherapy is recommended?
If you or a loved one are preparing to start R-CHOP treatment, speak with your oncology team about creating a personalized side-effect management plan. Understanding your schedule and having the right support in place can significantly improve your experience and help you focus on your recovery.
Frequently Asked Questions
What does the acronym R-CHOP stand for?
R-CHOP stands for the five drugs used in the treatment: Rituximab, Cyclophosphamide, Doxorubicin (Hydroxydaunomycin), Vincristine (Oncovin), and Prednisone. [1]
How is R-CHOP administered to the patient?
Four of the drugs (Rituximab, Cyclophosphamide, Doxorubicin, and Vincristine) are given through an intravenous (IV) infusion at a clinic or hospital. [1] The fifth drug, Prednisone, is a pill taken by mouth at home.
How long does a typical R-CHOP treatment session take?
The first session is usually the longest, often taking 8 to 10 hours, primarily due to the slow administration of Rituximab. Subsequent sessions may be shorter if the patient tolerates the medications well.
Is hair loss a guaranteed side effect of R-CHOP?
While not every single patient loses their hair, it is a very common side effect of the chemotherapy drugs in the R-CHOP regimen. [1] Hair typically begins to grow back several weeks after the final treatment cycle.
Why is my urine red after an R-CHOP infusion?
One of the drugs, doxorubicin, has a naturally red color. [1] It is normal and expected for your urine to appear pink or reddish for 24 to 48 hours after the infusion as your body clears the medication.
Can I work while undergoing R-CHOP treatment?
Some patients continue to work part-time or with adjusted schedules, but many find the fatigue significant. It is best to discuss your specific situation with your doctor and plan for extra rest during treatment weeks.
How many cycles of R-CHOP will I need?
Most patients receive six cycles, with each cycle lasting 21 days. [1] However, depending on the type and stage of the lymphoma, some doctors may recommend eight cycles or a different schedule.
What are the signs of an infusion reaction?
Common signs include feeling light-headed, flushed, or itchy during the infusion. More serious signs include a rash, swelling of the lips or throat, and difficulty breathing, which require immediate medical attention.
Does R-CHOP treat all types of lymphoma?
R-CHOP is specifically used for non-Hodgkin lymphomas, particularly B-cell types like diffuse large B-cell lymphoma and follicular lymphoma. [1] It is not typically used for Hodgkin lymphoma.
What happens after the six cycles are finished?
After completing the cycles, you will have follow-up scans and tests to check for remission. Your medical team will then monitor you regularly for several years to ensure the cancer does not return.
Related Reading
Diffuse Large B-Cell Lymphoma (DLBCL): Symptoms, Stages, Treatment & Survival — Complete Guide explains the lymphoma most often treated with R-CHOP.
Non-Hodgkin's Lymphoma: Symptoms, Causes, and Treatment Options Explained covers non-Hodgkin lymphoma types and treatment options.
Monoclonal Antibodies: What They Are, How They Work, Uses and Side Effects explains antibody drugs like the rituximab in R-CHOP.
Chemotherapy: How It Works, Side Effects, and What to Expect describes how chemotherapy works and how to handle side effects.
References
Cleveland Clinic. R-CHOP Chemotherapy. Cleveland Clinic Health Library. Accessed October 11, 2026. https://my.clevelandclinic.org/health/treatments/r-chop
Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood. 2010;116(12):2040-2045. PMID: 20548096. DOI: https://doi.org/10.1182/blood-2010-03-276246
Morschhauser F, Salles G, Sehn LH, et al. Five-year outcomes of the POLARIX study comparing Pola-R-CHP and R-CHOP in patients with diffuse large B-cell lymphoma. J Clin Oncol. 2025;43(35):3698-3705. PMID: 40991874. DOI: https://doi.org/10.1200/JCO-25-00925
Medical disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have about a medical condition.
Comments